Clinical Trial Update: Dexmedetomidine Combined With Hydromorphone in Tonsillectomy and Adenoidectomy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the combination of dexmedetomidine and hydromorphone in tonsillectomy and adenoidectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agitated State After Surgery
• Tonsillectomy-related Agitation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Hydromorphone (hydromorphone)

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Agitated; State, Acute Reaction to Stress | Phase 4 | Status: COMPLETED